Impact of Clonal Architecture on Clinical Course and Prognosis in Patients With Myeloproliferative Neoplasms.

Luque Paz, Damien; Bader, Michael S; Nienhold, Ronny; Rai, Shivam; Almeida Fonseca, Tiago; Stetka, Jan; Hao-Shen, Hui; Mild-Schneider, Gabriele; Passweg, Jakob R; Skoda, Radek C

Luque Paz, Damien; Bader, Michael S; Nienhold, Ronny; Rai, Shivam; Almeida Fonseca, Tiago; Stetka, Jan; Hao-Shen, Hui; Mild-Schneider, Gabriele; Passweg, Jakob R; Skoda, Radek C.

Afiliação

Luque Paz D; Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Switzerland.
Bader MS; Univ Angers, Nantes Université, CHU Angers, Inserm, CNRS, CRCI2NA, Angers, France.
Nienhold R; Division of Hematology, University Hospital Basel, Switzerland.
Rai S; Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Switzerland.
Almeida Fonseca T; Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Switzerland.
Stetka J; Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Switzerland.
Hao-Shen H; Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Switzerland.
Mild-Schneider G; Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Switzerland.
Passweg JR; Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Switzerland.
Skoda RC; Division of Hematology, University Hospital Basel, Switzerland.

Hemasphere ; 7(5): e885, 2023 May.

Article em En | MEDLINE | ID: mdl-37153874

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Hemasphere Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google